Carlsmed, Inc.
CARL
$14.50
$0.050.35%
NASDAQ
| 03/31/2025 | |||||
|---|---|---|---|---|---|
| Net Income | -5.18% | ||||
| Total Depreciation and Amortization | 0.00% | ||||
| Total Amortization of Deferred Charges | -- | ||||
| Total Other Non-Cash Items | 20.87% | ||||
| Change in Net Operating Assets | -22.46% | ||||
| Cash from Operations | -10.01% | ||||
| Capital Expenditure | -66.00% | ||||
| Sale of Property, Plant, and Equipment | -- | ||||
| Cash Acquisitions | -- | ||||
| Divestitures | -- | ||||
| Other Investing Activities | -- | ||||
| Cash from Investing | -376.00% | ||||
| Total Debt Issued | -- | ||||
| Total Debt Repaid | -- | ||||
| Issuance of Common Stock | 1,141.67% | ||||
| Repurchase of Common Stock | -- | ||||
| Issuance of Preferred Stock | -69.04% | ||||
| Repurchase of Preferred Stock | -- | ||||
| Total Dividends Paid | -- | ||||
| Other Financing Activities | -2,353.33% | ||||
| Cash from Financing | -69.61% | ||||
| Foreign Exchange rate Adjustments | -- | ||||
| Miscellaneous Cash Flow Adjustments | -- | ||||
| Net Change in Cash | -89.34% | ||||